Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Susmed: Demonstration of Clinical Data Managing System Using Blockchain Technology
April 22, 2019 Off

Susmed: Demonstration of Clinical Data Managing System Using Blockchain Technology

By BusinessWire

In this pilot project, the Susmed system uses blockchain technology, which isexpected to be more cost-effective than conventional methods inmonitoring of clinical researches and ensuring data accuracy duringmonitoring.

FSD Pharma Receives Cannabis Sales License from Health Canada
April 22, 2019 Off

FSD Pharma Receives Cannabis Sales License from Health Canada

By BusinessWire

The license allows the current FSD facility to supply and sell cannabisproducts. The company expects receiving the amended sales licensethat will include the sale of dried and fresh cannabis flower in thenear future.

Global Anticoagulants Reversal Drugs Market Covering Key Players & Their Competitive Strategies, 2019: Analysis & Outlook Through 2018-2026 – ResearchAndMarkets.com
April 19, 2019 Off

Global Anticoagulants Reversal Drugs Market Covering Key Players & Their Competitive Strategies, 2019: Analysis & Outlook Through 2018-2026 – ResearchAndMarkets.com

By BusinessWire

The global anticoagulants reversal drugs market expected to expand at aCAGR of 15.3% from 2018 to 2026, owing to the approval of blockbusterdrugs in recent years and strong pipeline driving the market.

April 19, 2019 Off

Anterior Uveitis – Pipeline Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Anterior Uveitis – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive…

April 19, 2019 Off

Worldwide Chemotherapy Drugs Market Outlook to 2023 – Featuring Pfizer, Eli Lilly, Celgene, Bristol-Myers Squibb, Merck & Co, GlaxoSmithKline, Novartis, Sanofi, and Teva Pharmaceutical Industries – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral,…

April 18, 2019 Off

Innovus Pharma Announces FDA Approval of New ANDA for Supply of FlutiCare®

By BusinessWire

Company Also Reaches Sales Milestone of 1,000 Units of FlutiCare® Sold per Day SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma”…

April 18, 2019 Off

Grossly Misleading “Short and Distort” Article Wrongfully Attempts to Dupe 22nd Century Group Shareholders

By BusinessWire

22nd Century exposes short seller as a promotor of incorrect and self-serving “fake news” WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc.…

April 18, 2019 Off

Global Pharmacovigilance Market by Clinical Trial Phase, Service Provider, Type, End-use and Region – Forecast to 2026 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Pharmacovigilance Market Size, Share & Trends Analysis Report By Clinical Trial Phase (Pre-Clinical, Phase I, II, III, IV),…

April 18, 2019 Off

Global $15.63Bn Stem Cell Market by Product, Application, Technology, Therapy, and Region – Forecast to 2025 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Stem Cell Market Size Analysis Report By Product (Adult, hESC, Induced Pluripotent), By Application (Regenerative Medicine, Drug Discovery…

April 18, 2019 Off

BioKansas to Host the 2019 Kansas BioGENEius Challenge Finals and Networking Reception on Thursday, April 25th

By BusinessWire

FAIRWAY, Kan.–(BUSINESS WIRE)–BioKansas is hosting the 2019 Kansas BioGENEius Challenge Finals on Thursday, April 25th, at the KU Edwards Campus.…

Posts pagination

Previous 1 … 5,868 5,869 5,870 … 6,212 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001

December 18, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine